An In Vivo Pharmacological Screen Identifies Cholinergic Signaling as a Therapeutic Target in Glial-Based Nervous System Disease.
about
Discovery of new muscarinic acetylcholine receptor antagonists from Scopolia tanguticaDrug Discovery in Fish, Flies, and Worms.A Conserved Cytoskeletal Signaling Cascade Mediates Neurotoxicity of FTDP-17 Tau Mutations In Vivo.Glial contributions to neuronal health and disease: new insights from Drosophila.A pharmacological screen for compounds that rescue the developmental lethality of a Drosophila ATM mutant.
P2860
An In Vivo Pharmacological Screen Identifies Cholinergic Signaling as a Therapeutic Target in Glial-Based Nervous System Disease.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
An In Vivo Pharmacological Scr ...... -Based Nervous System Disease.
@ast
An In Vivo Pharmacological Scr ...... -Based Nervous System Disease.
@en
type
label
An In Vivo Pharmacological Scr ...... -Based Nervous System Disease.
@ast
An In Vivo Pharmacological Scr ...... -Based Nervous System Disease.
@en
prefLabel
An In Vivo Pharmacological Scr ...... -Based Nervous System Disease.
@ast
An In Vivo Pharmacological Scr ...... -Based Nervous System Disease.
@en
P2093
P2860
P1476
An In Vivo Pharmacological Scr ...... -Based Nervous System Disease.
@en
P2093
Liqun Wang
Mel B Feany
Tracy L Hagemann
P2860
P304
P356
10.1523/JNEUROSCI.0256-15.2016
P407
P577
2016-02-01T00:00:00Z